Adagio Pharmaceuticals, Cynapsus deal

Cynapsus completed its acquisition of Adagio in a stock deal valued at C$520,000 ($509,340) based on Cynapsus' close of C$0.02 on Dec. 21, the day before the close was announced. Adagio shareholders w...